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ABSTRACT: 
Background  
Although alterations in medial temporal lobe structures have been previously associated with use of 
cannabis, one of the most widely used illicit drugs, whether such alterations are a cause or effect of 
cannabis use has been unclear.  
 
Methods 
In this cross-sectional observational study involving 404 twins/siblings, we have compared cortical 
thickness and surface area between groups of gender-matched sibling-pairs (concordant cannabis 
unexposed, concordant exposed and discordant for cannabis exposure) using permutation tests after 
controlling for potential confounds. Bi-variate polygenic model was used to assess the genetic and 
environmental contributions underlying cortical morphological phenotypes and frequency of 
cannabis use. 
  
Results 
Cortical thickness of the right entorhinal cortex was significantly lower in the concordant exposed 
siblings compared to both discordant unexposed and discordant exposed groups (FDR corrected, q 
< 0.05). The association between the right entorhinal cortex thickness and frequency of cannabis 
use is due to the contribution of significant shared additive genetic (ρg = -0.19 ± 0.08; p = 0.02) 
factors but not unique environment (ρe = 0.05± 0.09; p = 0.53). Significantly lower surface area of 
the right entorhinal cortex in discordant exposed group compared to the discordant unexposed 
group furnishes preliminary evidence in support of causal effect of cannabis use (FDR corrected, q 
< 0.05). However, bi-variate polygenic model based analysis did not show any significant effect.            
 
Conclusions 
Shared genetic liability may underlie the association between cannabis exposure and thinner right 
entorhinal cortex. Prospective longitudinal studies are necessary to definitively disentangle the 
cause-effect relationships of cannabis use. 
 
KEYWORDS: genetic liability, twins, cortical thickness, surface area, cannabis 
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INTRODUCTION 
Worldwide, cannabis remains one of the most widely used illicit drugs (United Nations, 2016) 
which is associated with a number of adverse mental and psychosocial outcomes (Crippa et al., 
2009, Marconi et al., 2016, Meier et al., 2012, Moore et al., 2007, Patel et al., 2016, Schoeler et al., 
2016a, Schoeler et al., 2016b, Schoeler et al., 2016c, Schoeler et al., 2016d, Schoeler et al., 2016e). 
Hence, effects of cannabis use on brain structure and function that may underpin its effects on 
cognition and behaviour are of particular interest, more so in light of the legislative changes 
governing its use, for example in the United states (Volkow et al., 2016). The residual cognitive 
effects of cannabis use have been most robustly observed in memory (Grant et al., 2003) and its 
various sub-domains (Schoeler et al., 2016a) suggesting that the medial temporal lobe (MTL) 
structures, which play a critical role in learning and memory (Eichenbaum et al., 2007), are of 
particular interest in terms of the effects of cannabis use on their structure and function. 
Pharmacological challenge studies offering greater experimental control consistently show acute 
effects of cannabinoids on MTL function using fMRI (Batalla et al., 2014, Bhattacharyya et al., 
2015a, Bhattacharyya et al., 2012a, Bhattacharyya et al., 2012b, Bhattacharyya et al., 2017, 
Bhattacharyya et al., 2015b, Bhattacharyya et al., 2009, Bhattacharyya et al., 2010, Bhattacharyya 
et al., 2018, Borgwardt et al., 2008, Bossong et al., 2014, Bossong et al., 2013, Phan et al., 2008). 
However, studies investigating the long-term effects of cannabis use on brain structure and function 
have been less consistent in terms of effects on MTL structure and function (reviewed here (Batalla 
et al., 2013, Lorenzetti et al., 2014)), potentially because of modest sample sizes, differing degrees 
of cannabis exposure, genetic differences between participants and potential differences in strains of 
cannabis used by them (Bhattacharyya et al., 2012a, Bhattacharyya et al., 2015b, Bhattacharyya et 
al., 2014, Bhattacharyya et al., 2010). Furthermore, available evidence from cross-sectional studies 
do not help disentangle whether group differences in brain structure and function are a result of 
cannabis use or alternatively may predispose to cannabis use. In the absence of ethically 
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impermissible randomised controlled studies involving long-term experimental treatment with 
cannabis or placebo or logistically complex longitudinal study designs with multipoint assessment 
over the life course (Schoeler et al., 2016e), cross-sectional observational studies using sibling or 
twin data offer the best possibility of disentangling cause and effect relationships. Using this 
approach Pagliaccio and colleagues (Pagliaccio et al., 2015) have recently shown that cannabis 
exposure was associated with smaller left amygdala volume, which was attributable to shared 
predispositional factors rather than being a consequence of cannabis use. In another large study, 
adolescent cannabis use was associated with lower mean cortical thickness (across the entire cortex) 
in males with a high genetic risk for schizophrenia (French et al., 2015) with the largest differences 
between those exposed and those unexposed to cannabis being in brain regions with high 
cannabinoid receptor expression, e.g., entorhinal and anterior cingulate cortex. However, conflicting 
evidence has emerged from smaller studies that have examined the relationship between cannabis 
exposure and cortical thickness measures especially in the entorhinal cortex (Jacobus et al., 2015, 
Jacobus et al., 2014).  
Within the MTL structures that play a critical role in mnemonic processing, evidence suggests 
distinct contributions of different regions of the medial temporal cortex to memory. While the 
hippocampus plays a critical role in the recall of information along with the parahippocampal 
cortex, the entorhinal and perirhinal cortices are particularly necessary for familiarity-based 
recognition (Eichenbaum et al., 2007). In particular, the entorhinal and adjacent parahippocampal 
cortices are thought to be involved in the representation of object-related and spatial information 
during encoding (Navarro Schroder et al., 2015, Schultz et al., 2015). The entorhinal and adjacent 
parahippocampal cortices are of particular interest in terms of the effects of cannabis use as 
unimodal and polymodal neocortical projections that bring information to the hippocampus for this 
to be bound into an integrated memory trace, pass through them before they converge on the 
hippocampus (Munoz and Insausti, 2005, Navarro Schroder et al., 2015). Furthermore, the 
relationship between cannabis expsoure and hippocampal and amygdala structure has already been 
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investigated using the HCP cohort in a couple of other studies. For example, Pagliaccio and 
colleagues (Pagliaccio et al., 2015) did not find evidence of an association between cannabis use 
and hippocampal volume supportive of either causal or predispositional relationship. Another study 
by Orr and colleagues (Orr et al., 2016) has also investigated the parametric relationship between 
cannabis use measures and white matter intergity as well as volume and shape of cortical and 
subcortical structures using a larger dataset from the HCP cohort. They showed an association 
between number of times of cannabis use over lifetime and the shape of amygdala and 
hippocampus. On the other hand, the precise direction of change in the thickness and surface area of 
the entorhinal and parahippocampal cortices, in relation to cannabis use and whether such changes 
are a cause or consequence of cannabis use is unclear (Jacobus et al., 2015, Jacobus et al., 2014). 
Hence, the primary objective of the present study was to employ the sibling-pair design using data 
collected as part of the Human Connectome Project (HCP)  to investigate the nature of the 
relationship between cannabis use and thickness and surface area of the entorhinal and 
parahippocampal cortices. While cortical volume alterations have often been the focus of 
investigations in the context of cannabis use (reviewed in Batalla et al PloS One 2013  and 
(Lorenzetti et al., 2016), there has been growing acceptance that cortical volume is a composite 
measure that is principally determined by two dimensions of the cortical sheet, i.e., its surface area 
and thickness and focus on the cortical volume measure alone can obscure information about these 
two distinct determinants of cortical volume ((Im et al., 2008, Raznahan et al., 2011, Tamnes et al., 
2017) Specific focus on cortical thickness and surface area is particularly important as they capture 
the effects of distinct developmental, evolutionary, genetic and cellular processes (Chen et al., 2013, 
Geschwind and Rakic, 2013, Lyall et al., 2015, Panizzon et al., 2009, Raznahan et al., 2011, Storsve 
et al., 2014, Tamnes et al., 2017, Wierenga et al., 2014) as well as experiences (French et al., 2015, 
Park et al., 2009, Sirevaag and Greenough, 1988). Given the organization of the cerebral cortex into 
columnar functional units (Mountcastle, 1997), it is thought that surface area of the cortex is 
influenced by the number of functional columns, while cortical thickness is influenced by the 
6 
 
number of cells in these columns (Rakic, 1988, 1995, 2007). In light of previous evidence 
(summarized earlier), we hypothesized that changes in cortical thickness and surface area in the 
entorhinal and parahippocampal cortices would reflect a causal effect of cannabis use on these 
structures rather than reflecting shared predisposition. Specifically, we hypothesized that cannabis-
exposed siblings from gender-matched sibling pairs discordant for cannabis exposure would have 
significantly thinner entorhinal and parahippocampal cortices and smaller surface area of these 
regions compared to siblings not exposed to cannabis from the same gender-matched sibling pairs 
discordant for cannabis exposure. We also hypothesized that the cortical thickness and surface area 
of these regions from both groups of siblings (i.e., cannabis-exposed and non-exposed) from sibling 
pairs discordant for cannabis exposure would not be significantly different from sibling pairs who 
were both exposed to or not exposed to cannabis. 
 
MATERIALS AND METHODS 
Participants 
All data were obtained from the S900 release (December, 2015) of data collected as part of the 
Human Connectome Project (HCP) (https://db.humanconnectome.org/), which plans to recruit 1200 
twins and non-twin siblings  excluding individuals whose siblings have neuropsychiatric, 
neurologic or severe neurodevelopmental disorders, but including persons with history of alcohol or 
recreational substance use who did not need inpatient treatment for ≥2 days or specialist treatment 
(for detailed exclusion/inclusion criteria please see (Van Essen et al., 2012)). For the present 
analyses, participants were excluded if pertinent interview/questionnaire/neuroimaging data were 
missing or where there was discrepancy between self-report information and related test result (eg. 
positive urine test result for tetrahydrocannabinol with negative self-report) or in the absence of a 
gender-matched sibling. HCP data collection and public release were approved by the Institutional 
Review Board (IRB) of University of Washington in St. Louis (IRB # 201204036; Title: ‘Mapping 
the Human Connectome: Structure, Function, and Heritability’).  
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Information on Cannabis use 
Cannabis exposure was assessed using the Semi-Structured Assessment for the Genetics of 
Alcoholism (SSAGA) (Bucholz et al., 1994). Lifetime exposure to cannabis was coded as a 
dichotomous categorical variable (1= yes, 0= no). Ordinal coding schemes were used to represent 
the reported age of first use of cannabis and information on frequency of lifetime cannabis use 
(defined as total number of times of reported cannabis use over lifetime). HCP codes for these two 
measures were as follows:  age of first use (<=14 year = 1; 15-17 year = 2; 18-20 year = 3; >=21 
year = 4) and frequency (never = 0; 1-5 = 1; 6-10 = 2; 11-25 = 3; 26-50 = 3; 51-100 = 3; 101-999 = 
4; 1000-2000 = 5; >2000 = 5). 
Neuro-anatomical data 
T1-weighted brain images were acquired using a customized 3T Siemens Skyra scanner employing 
a 3D MPRAGE sequence with the following pulse-sequence parameters:  FOV = 224 mm, matrix 
size =320, number of sagittal slices = 256, voxel dimension = 0.7 mm isotropic, TR = 2400 ms, TE 
= 2.14 ms, T1 = 1000 ms, FA = 8 degree, BW = 210 Hz per pixel, Echo Spacing = 7.6 ms, GRAPPA 
factor = 2. MR gradient nonlinearity-induced distortions of the individual T1-weighted images were 
corrected using FreeSurfer's package (gradient_nonlin_unwarp)(Fischl, 2012). T1-weighted images 
were aligned by rigid registration (degree of freedom= 6) using FMRIB’s Linear Image Registration 
Tool (FLIRT) from FMRIB Software Library (FSL) (Jenkinson et al., 2012) followed by FNIRT 
(FMRIB’s Nonlinear Image Registration Tool) based non-linear registration. After intensity 
normalization, images were processed using the appropriate FreeSurfer pipeline (recon-all) to 
estimate cortical thickness and surface area of the regions of interest (left and right 
parahippocampal gyri and left and right entorhinal cortices). Brain regions were defined as per 
Desikan-Killiany atlas (Desikan et al., 2006). MR image acquisition and image processing methods 
are detailed in Glasser et al (Glasser et al., 2013).    
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Causal, Graded liability and Predisposition Hypotheses 
Gender-matched sibling pairs were classified into four groups based on their reported lifetime 
cannabis use. Sibling pairs who were both unexposed to cannabis were assigned to the ‘Concordant 
Unexposed’ (CU) group. Discordant Exposed (DE) and Discordant Unexposed (DU) groups 
included those members of the sibling pairs discordant for cannabis exposure who were exposed to 
or were not exposed to cannabis respectively. Where both members of sibling pairs were exposed to 
cannabis, they were assigned to the Concordant Exposed (CE) group.  
The Causal Hypothesis tested whether cannabis exposure caused changes in cortical thickness or 
surface area.  As siblings reared together share 50% of their genes and a similar rearing 
environment, any observed differences in brain structure between Discordant Unexposed and 
Discordant Exposed groups were likely to provide preliminary support for the causal hypothesis, 
which would need confirmation by comparing monozygotic twin pairs discordant for cannabis use.  
The Graded liability and Predisposition hypotheses tested whether shared genetic or familial factors 
predispose to both cannabis use and changes in cortical thickness or surface area. To test the Graded 
liability hypothesis, Discordant Unexposed and Discordant Exposed groups were separately 
compared to the Concordant Exposed group. Significant differences would imply that the 
Concordant Exposed sibling pairs were at altered liability compared to the discordant pairs, as both 
siblings were exposed to cannabis in the Concordant Exposed  group compared to only one member 
of the sibling pairs in Discordant group. To test the Predisposition hypothesis, Concordant 
Unexposed   group was compared with all the other three groups to test whether the differences in 
neuro-anatomical measures and cannabis use were related to a shared predisposition, but that 
liability did not differ on the basis of concordance or discordance for cannabis exposure.  
Following extreme-outlier removal (Tukey, 1977) there were N=152, N=51, N=51 and N=174 
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siblings in the Concordant Unexposed  , Discordant Unexposed , Discordant Exposed  and 
Concordant Exposed  groups respectively constituting total 214 gender-matched sibling pairs (84 
monozygotic, 69 dizygotic and 61 non-twin sibling pairs). 214 siblings have reported exposure to 
cannabis out of total 404 siblings included in this study. Further details about these sibling groups 
are available in Supplementary Table 1. 
 
Potential Confounds 
Gender (Lv et al., 2010), ethnicity, zygosity, age (Thambisetty et al., 2010), height, weight, total 
cortical surface area, average cortical thickness,  total household income, picture vocabulary 
measure ( as a proxy of IQ) (Menary et al., 2013), handedness (Li et al., 2015), NEO Five Factor 
Inventory (NEO-FFI) personality measures (Wright et al., 2006) (conscientiousness, 
extroversion/introversion, neuroticism, openness, agreeableness), delayed discounting 
(impulsivity/self-regulation) (Schilling et al., 2013), depressive symptoms (Lev-Ran et al., 2014), 
childhood conduct problem (Hyatt et al., 2012) and alcohol (Wagner and Anthony, 2002) (drinks/ 
day), nicotine (Kuhn et al., 2010, Wagner and Anthony, 2002) (cigarettes smoked/day) and other 
illicit drug (Wagner and Anthony, 2002) (number of times used during lifetime ) use were 
considered as confounders (additional details in Supplementary Information). 
Potential confounding variables were compared between the groups using Fisher's exact test for 
categorical and unpaired t-tests for other variables and those significantly (p < 0.05) different 
between the groups were included as confounders for group comprisons of neuroanatomical 
measures using the Permutation Analysis of Linear Models (PALM) tool (Winkler et al., 2014). 
Hypothesis-specific confounders that we controlled for during the comparison of means of cortical 
thickness and surface area are listed here: Causal Hypothesis (use of alcoholic drinks, cigarette use, 
illicit drug use), Graded liability hypothesis (Zygosity, Ethnicity, Delay-discounting, use of 
alcoholic drinks, cigarette use, illicit drug use) and Predisposition hypothesis (Zygosity, Ethnicity, 
Delay-discounting, use of alcoholic drinks, cigarette use, illicit drug use). As average whole brain 
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cortical thickness was also significantly (p < 0.05) different between the groups, the average whole 
brain cortical thickness variable was entered as an additional confounder while comparing cortical 
thickness between the groups. The following confounds were significantly (p < 0.05) associated 
with cortical thickness and surface area: Cortical thickness (Age, Zygosity, Ethnicity, Picture 
vocabulary, Delay-discounting, use of alcoholic drinks, cigarette use, illicit drug use, average 
cortical thickness); Surface area (Age, Zygosity, Ethnicity, Picture vocabulary, Delay-discounting, 
use of alcoholic drinks, cigarette use, illicit drug use, total cortical surface area). Hence, we have 
controlled for these confounds while computing the correlation between cannabis use variables and 
neuro-anatomical data.  
 
Statistical analysis  
Frequency of cannabis use and age of onset of cannabis use measures were compared between the 
disconcordant cannabis-exposed siblings and concordant cannabis-unexposed sibling groups using 
unpaired t-tests.  Permutation tests were performed to assess the mean difference in neuro-
anatomical measures between the groups after controlling for the potential confounding variables 
under the General Linear Model (GLM) framework using the PALM tool (Winkler et al., 2014) of 
FSL. During the permutation tests, two permutation blocks were defined according to the two 
groups of subjects and 20,000 random sign-flippings were used (Winkler et al., 2014). Spearman's 
partial rank correlation between neuro-anatomical and cannabis use measures in the cannabis-
exposed individuals (N = 214) were computed after controlling for potential confound variables. 
Cannabis use measures between the siblings of concordant cannabis-exposed sibling pairs were 
correlated using Spearman's rank correlation.  
As a preliminary test of the Causal hypothesis that cannabis use was causally associated with 
aletrations in the thickness and surface area of entorhinal and parahippocampal cortices, we 
compared the Discordant Unexposed and Discordant Exposed  groups. As this groups were not 
significantly different, we did not carry out a confirmatory test for the causal hypothesis by 
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comparing monozygotic twin pairs discordant for cannabis use. In order to test the Graded liability 
hypothesis, we compared Discordant Unexposed and Discordant Exposed groups separately to the 
Concordant Exposed  group. Finally, we compared the Concordant Unexposed  group with all the 
other three groups to test the Predisposition hypothesis. 
 
Estimation of heritability and shared additive genetic effects 
Heritability estimation was carried out for those neuroanatomical measures that satisfied tests for 
either causal, predisoposition or liability hypotheses as being related to cannabis use and included 
average cortical thickness, total cortical surface area, frequency of cannabis use and cortical 
thickness/surface area of the specific brain region of all sibling pairs. Phenotypic correlation (ρp) 
between the neuroanatomical measure and the frequency of cannabis use was estimated and 
decomposed into shared additive genetic (ρg) and individual environmental (ρe) factors using the bi-
variate polygenic model (Blangero et al., 2013). We assumed that siblings with identical biological 
parents lived within a common environment. We employed the SOLAR (Sequential Oligogenic 
Linkage Analysis Routine)-Eclipse software (http://solar-eclipse-genetics.org/) for heritability 
estimations and bi-variate polygenic model-based analyses. Gender, age, ethnicity, total household 
income, personality measures, picture vocabulary test performance score and delayed discounting 
performance scores were controlled for during heritability analyses. Average cortical thickness and 
total cortical surface area were additionally controlled for while estimating heritability of regional 
cortical thickness and surface area respectively. Heritability of the frequency of cannabis use was 
estimated after controlling for the use of alcohol, nicotine and other illicit drugs.  
 
 
RESULTS 
Characteristics of the participants 
Cannabis exposed individuals were significantly more open to experiences (p= 0.0028) than 
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unexposed individuals (as indexed using NEO-FFI Openness) (Table 1). There was a significant 
association between cannabis exposure and race, with non-white individuals having 1.75 times 
greater odds of being exposed to cannabis than those from the white race (p= 0.01). Cannabis 
exposed individuals had 16.94 times greater odds of alcohol exposure (p< 0.0003), 6 times greater 
odds of cigarette smoking (p< 10-16)  and 21.22 times greater odds of exposure to other illicit drugs 
(p< 10-18) than those not exposed to cannabis. Among the cannabis users, 49.53 % reported onset of 
cannabis exposure under the age of 18 and 16.36 % satisfied SSAGA criteria of cannabis 
dependence. 31.31% of the cannabis-exposed individuals using cannabis more than 100 times 
during their lifetime (Table 1).  
 
Cannabis exposures in concordant and discordant siblings 
Cannabis use started significantly (p= 0.0067) earlier in sibling-pairs who were both exposed to 
cannabis that those who were not (Figure 1a). However, there was no significant difference between 
the two groups in terms of mean cannabis use frequency (Figure 1b). Age of first use of cannabis 
was significantly correlated (ρ = 0.49, p= 2.8 x 10-6) between the sibling pairs of the concordant 
exposed groups.  Frequency of cannabis use was also significantly (ρ = 0.41, p= 1 x 10-4) correlated 
between these sibling pairs. 
  
Cortical thickness 
Cortical thickness of the right entorhinal cortex was significantly reduced (FDR-corrected, q< 0.05) 
(Figure 2a, Table 2) in Concordant Exposed siblings compared to both Discordant Unexposed  and 
Discordant Exposed  groups supporting the graded liability hypothesis. When sibling-pairs 
belonging to the Discordant Exposed group were investigated, the right entorhinal cortex thickness 
of the siblings exposed to cannabis were not significantly different from their Discordant 
Unexposed siblings. However, when both siblings were exposed to cannabis, as in the case of those 
belonging to the Concordant Exposed group, their entorhinal cortex was thinner compared to 
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siblings belonging to Discordant Exposed groups. Together, these results supported the graded 
liability hypothesis suggesting that shared genetic liability or rearing environment increase the 
liability for both reduced thickness of the right entorhinal cortex and cannabis use or that reduced 
thickness of the right entorhinal cortex may increase the liability to cannabis use in a graded 
manner, such that the risk was greater in sibling pairs concordantly exposed to cannabis use 
compared to when only one of the siblings from the sibling pairs was unexposed (discordant pairs).  
 
However, there was no evidence in support of the causal and predisposition hypotheses. Age of first 
use of cannabis was significantly (ρ = 0.14, p= 0.022) correlated with the right entorhinal cortex 
thickness in the cannabis exposed participants. Such a relationship was not observed between 
cannabis use parameters and cortical thickness for any of the other brain regions considered (p> 
0.05). 
   
Surface area 
Mean surface area of the right entorhinal cortex of the Discordant Exposed siblings was 
significantly (FDR-corrected, q< 0.05) smaller than their Discordant Unexposed siblings (Figure 
2b), supporting the causal hypothesis that reduced right entorhinal cortex surface area was an effect 
of cannabis use. However, there was no evidence in support of the graded liability and 
predisposition hypotheses. Frequency of cannabis use was significantly (ρ= - 0.13, p= 0.020) 
correlated with surface of the right entorhinal cortex in the cannabis exposed participants. 
Correlation between cannabis use parameters and cortical surface area of other brain regions tested 
were not significant (p> 0.05). 
 
Heritability analysis and genetic and environmental contributions to phenotypic 
measures  
Total cortical surface area, average cortical thickness, right entorhinal cortex thickness and surface 
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area were significantly heritable (p < 10-6 ; Table 3). Frequency of cannabis use was also 
significantly heritable (0.45±0.08, p< 10-6). There was significant phenotypic (ρp= -0.10; p= 0.02) 
correlation between right entorhinal cortex thickness and frequency of cannabis use, which was a 
result of significant shared additive genetic (ρg = -0.19 ± 0.08; p= 0.02) but not unique 
environmental (ρe= 0.05± 0.09; p= 0.53) correlation. Phenotypic, genetic and individual 
environmental correlations between surface area of the right entorhinal cortex and frequency of 
cannabis use were not significant (p> 0.05).  Common rearing environment did not contribute 
significantly (p> 0.05) to these measures.  
  
 
DISCUSSION 
In the present study, we investigated the nature of the relationship between cannabis use and cortical 
thickness and surface area of the entorhinal and parahippocampal cortices using the largest sibling-
pair sample investigated to date. As predicted, we found that reduced thickness and surface of the 
right entorhinal cortex were associated with cannabis use in this sample, which persisted even after 
correcting for a number of potential confounders. Such an association was not found in the 
entorhinal cortex on the left side or in the parahippocampal cortex bilaterally. Furthermore, contrary 
to our expectations, we found that the association between reduced right entorhinal cortex thickness 
and cannabis use reflected the effect of a shared factor (eg. genetic or environmental) that is likely 
to have increased the liability to both cannabis use and reduced cortical thickness in a graded 
manner, such that the risk was greater in sibling pairs concordantly exposed to cannabis use 
compared to when one of the siblings from the sibling pairs was unexposed (discordant pairs). 
Whilst this may suggest that this liability factor may have resulted in reduced thickness of the right 
entorhinal cortex, which in turn may have increased the risk of cannabis use, it is also possible that 
this liability factor may have increased the risk of both cannabis use and of thinner entorhinal 
cortex. Additional analyses suggested that this association was likely a result of shared genetic 
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liability as opposed to shared or unique environmental influence, the latter providing further support 
against a causal effect of cannabis use on right entorhinal cortical thickness. 
These results are consistent with previous evidence of association between entorhinal cortex 
thickness and cannabis use (French et al., 2015, Jacobus et al., 2015, Jacobus et al., 2014) but 
extend it by suggesting that shared genetic liability may underlie the association between cannabis 
exposure and thinner right entorhinal cortex. However, whether genetic liability results in thinner 
right entorhinal cortex which in turn increases the risk of cannabis use behaviour remains to be 
tested. How thinner entorhinal cortex may increase the liability of cannabis use is unclear and may 
reflect the role of stress/ emotional dysregulation in drug use behaviour  (Koob and Volkow, 2016, 
Volkow et al., 2017), given its connectivity with regions implicated in emotional processing and 
reward-related learning (Oades and Halliday, 1987, Schultz et al., 2015, Sugase-Miyamoto and 
Richmond, 2007, Tomas Pereira et al., 2016). Furthermore, evidence from preclinical research 
suggests that the entorhinal cortex is critical for learning the motivational significance of stimuli 
(Liu et al., 2000), as well as for using memory of previous rewards to estimate the value of future 
rewards (Clark et al., 2012) and reciprocal connections of the entorhinal cortex with the orbital 
prefrontal cortex play a critical role in evaluating and estimating the expected value of rewards 
suggesting a role in modulating behaviour in response to expected reward value (Clark et al., 2013). 
Therefore, one may speculate that thinner entorhinal cortex may increase the liability of cannabis 
use in man by interfering with its critical role in helping modulate of behaviour in light of expected 
reward value through impairment in the estimation and learning of the motivational significance of 
drugs and evaluation of drug use in light of past adverse experience. However, the present data does 
not allow us to test these hypotheses. It is also worth noting in this context that, orbitofrontal cortex 
sulcogyral pattern, a structural variation that is established early on in life and thought to remain 
relatively stable thereafter, has been linked to a predisposition for greater levels of cannabis use 
over lifetime, in the absence of a contribution to the risk of becoming a cannabis user (Chye et al., 
2017).  
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These results are to be considered in light of certain limitations of the present sample as well as the 
study design. Firstly, accurate characterisation of temporal sequence of exposure and cause/ effect 
through multi-point brain imaging and exposure data collection within prospective longitudinal 
designs are necessary to definitively disentangle cause and effect relationships. This was not 
possible with the present data and need to be carried out in future studies. Limited by the very 
nature of the present cohort, information on cannabis use was not as detailed as would have been 
necessary to systematically examine dose-response relationships, also important for evaluating the 
nature of such associations. In particular, we were not able to differentiate between cannabis users 
who quit from those who continued to use. Future studies need to examine these groups separately 
to investigate whether the neural correlates of liability to use cannabis may differ between those 
who continue to use compared to those who stop. It is also worth noting that we focused on specific 
brain regions of interest, namely the entorhinal and parahippocampal cortices rather than employ a 
whole brain analysis approach or consider other brain regions high in cannabinoid receptors. 
Instead, we employed a hypothesis-driven approach, focusing on brain areas that subserve a 
cognitive function (i.e. memory) for which there is robust evidence of impairment associated with 
cannabis use both in experimental and observational studies. This was done to ensure that sample 
size of the groups tested based on their sibship information, cannabis use and gender leant them 
adequate power to detect significant differences with confidence, which would not have been 
feasible had we investigated multiple other brain regions. Finally, the present study was also limited 
by the number of twin pairs with and without exposure of interest and in particular the number of 
discordant monozygotic twin pairs for whom data was available.  
Nevertheless, these results suggest that thinner right entorhinal cortex may be associated with 
genetically mediated liability to cannabis use behaviour and underscore the importance of 
longitudinal studies to confirm the nature of this association as well as investigate potential 
cognitive mechanisms that may underlie it. Independent replication of these results as well as 
characterisation of the cognitive mechanisms that may underlie the association between entorhinal 
17 
 
thinnning and cannabis use behaviour is necessary for a clear understanding of the precise clinical 
significance of these results. 
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                                                    Figure Legends 
Figure 1 
 
Mean (SD) ordinal values corresponding to the age of onset of cannabis use and the 
frequency of lifetime cannabis use of Concordant Exposed (CE) and Discordant Exposed 
(DE) groups have been displayed in (a) and (b) respectively. 
 
Figure 2 
 
Mean (SE) values of the cortical thickness of the right entorhinal cortex related to the 
graded liability hypothesis have been displayed in (a). Mean (SE) values of the surface 
area of the right entorhinal cortex related to the causal hypothesis have been displayed in 
(b). DU, DE and CE refer to the Discordant Unexposed, Discordant Exposed and 
Concordant Exposed sibling groups respectively.  
 
Figure(1) Click here to download Figure(s) Figure_1.tif 
Figure(2) Click here to download Figure(s) Figure_2.tif 
Table 1. Characteristics of the 404 siblings.   
 
 
Group differences of the first 10 variables were tested using unpaired t-tests. For 
subsequent 9 variables, we have used Fisher’s exact tests. AUC: Area Under Curve, 
NEO-FFI: NEO Five Factor Inventory, SSAGA: Semi-Structured Assessment for the 
Genetics of Alcoholism. 
 
 
 
Sample characteristics                    Cannabis Unexposed         Cannabis Exposed          p-value 
                                                       (N= 190)  Mean (SD)        (N = 214)   Mean (SD)    
 
Age (years)                                                    29.19 (3.59)                29.14 (3.35)               0.86 
Handedness                                                    63.31 (48.56)              68.39 (41.85)            0.26 
Delay discounting (AUC)                              0.26 (0.21)                  0.23 (0.19)                0.17 
Age adjusted picture vocabulary                   107.58 (14.52)            107.02 (15.30)          0.71  
Total household income                                5.19 (2.13)                  5.10 (2.13)                 0.65 
NEO-FFI  Openness                                      26.65 (5.54)                28.45 (6.35)               0.0028 
NEO-FFI  Contentiousness                           34.86 (6.00)                34.48 (6.12)               0.53 
NEO-FFI  Neuroticism                                  16.47 (6.34)                15.79 (6.96)               0.31 
NEO-FFI  Extraversion                                 30.15 (6.40)                31.28 (5.98)               0.07 
NEO-FFI Agreeableness                               32.73 (5.25)                32.00 (4.76)               0.15 
Childhood conduct problem (%)                   36.32                          42.06                         0.26  
Depression history (%)                                  15.79                          22.43                         0.10  
Male (%)                                                        35.26                          40.65                         0.30   
White (%)                                                      77.89                           66.82                        0.01 
Twin (%)                                                        80.00                           71.5                          0.06 
Monozygotic twin (%)                                   48.21                           35.51                        0.01  
Never smoked cigarettes (%)                         75.26                           33.65                      < 10-16  
Never used illicit drugs (%)                            97.37                          63.55                      < 10-18 
Alcoholic drinks/day >2                                
(during heaviest 12 months period)                40.00                          74.30                       < 0.0003                                          
Age of onset (Cannabis use) < 18 years                 -                                49.53      
Lifetime cannabis use > 100 times                   -                                31.31        
Cannabis dependence (SSAGA criteria)         -                                 16.36 
Table(1) Click here to download Table(s) Table_1.doc 
 Table 2. Results of  PALM- based statistical comparisons of neuro-anatomical measures between the sibling groups  
 
 
                                             p-values (cortical thickness) 
Sibling groups        _______________________________________ 
                                 Left                 Left                  Right           Right  
                            Entorhinal  Parahippocampal Entorhinal Parahippocampal  
 
                           p-values (surface area) 
    _________________________________________ 
    Left                 Left                 Right              Right 
Entorhinal  Parahippocampal Entorhinal Parahippocampal 
Causal Hypothesis 
 
DU vs DE                0.72                 0.72                 0.82               0.82 
 
Graded Liability Hypothesis 
 
DU vs CE                0.02                 0.82                 0.0001*          0.91 
DE  vs CE                0.19                 0.49                 0.003*            0.35 
 
Predisposition Hypothesis 
 
CU vs CE                0.32                  0.59                0.0002*          0.79 
CU vs DE                0.89                  0.64                0.80                0.84 
CU vs DU               0.69                  0.42                 0.68               0.71 
   Causal Hypothesis 
     
    0.47                 0.93                0.006*               0.04 
 
Graded Liability Hypothesis 
 
    0.69                 0.66                0.49                 0.20 
    0.62                 0.38                0.93                 0.79 
 
Predisposition Hypothesis 
   
  0.01                 0.03                0.09                 0.003* 
  0.09                 0.38                0.003*             0.02 
  0.06                 0.08                0.20                 0.10 
 
* FDR (false discovery rate) corrected, q < 0.05 
DU: Discordant Unexposed, DE: Discordant Exposed, CE: Concordant Exposed, CU: Concordant Unexposed 
Table(2) Click here to download Table(s) Table_2.doc 
Table 3 Results of SOLAR analysis 
SOLAR                  Average cortical    Total cortical        Right Entorhinal      Right Entorhinal 
estimates                 thickness                surface area         thickness                  surface area 
Heritability (SE)    0.83 (0.03)             0.92 (0.1)             0.47(0.06)                0.53 (0.06) 
p                              < 10-6                                     < 10-6                                 < 10-6                                        < 10-6                                
Phenotypic             -0.15                        0.06                    -0.10                          -0.08 
correlation    
p                               0.002                       0.20                      0.02                          0.10 
Genetic                  -0.21 (0.07)            -0.04 (0.09)          -0.19 (0.08)              -0.11 (0.13) 
correlation (SE) 
p                               0.004                     0.66                        0.02                          0.41 
Environmental       0.02 (0.10)             -0.18 (0.11)           0.05 (0.09)                -0.05 (0.09) 
correlation (SE) 
p                              0.85                        0.11                        0.53                           0.56 
Table(3) Click here to download Table(s) Table_3.doc 
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 A. Supplementary Table 1 
 
      Characteristics of the sibling groups.   
 
 
Characteristics                                                Concordant Unexposed  Discordant Unexposed  Discordant Exposed  Concordant Exposed 
                                                                        (n=152) Mean (SD)        (n=51) Mean (SD)         (n=51) Mean (SD)    (n=174) Mean (SD) 
Age (yr)                                                                        29.47 (3.63)                28.98 (3.36)                     28.75 (3.30)               29.03 (3.43) 
Handedness                                                                  64.77 (47.32)              57.65 (51.16)                   69.02 (32.60)             68.62 (43.47) 
Delay discounting (AUC)                                            0.28 (0.22)                  0.22 (0.20)                       0.21 (0.19)                 0.25 (0.19) 
Age adjusted picture vocabulary                                 108.73 (14.11)            105.59 (14.56)                  107.01 (14.55)           107.04 (15.49) 
Total household income                                               5.17 (2.07)                  5.04 (2.18)                       4.90 (2.23)                 5.11 (2.10) 
NEO-FFI  Openness                                                     26.51 (5.57)                27.35 (5.49)                     28.25 (5.72)              28.50 (6.47) 
NEO-FFI  Contentiousness                                          34.60 (6.26)                35.63 (4.82)                     35 (6.55)                   34.14 (6.12) 
NEO-FFI  Neuroticism                                                15.51 (6.31)                17.53 (6.83)                     17.39 (6.25)               15.20 (6.98) 
NEO-FFI  Extraversion                                                30.05 (6.35)               30.49 (5.88)                      30.73 (6.42)              31.55 (6.00) 
NEO-FFI Agreeableness                                              33.03 (5.38)               32.31 (4.55)                       31.71 (5.10)              32.03 (4.62) 
Childhood conduct problem (%)                                  32.89                          37.25                                  33.33                        41.95 
Depression history (%)                                                 7.89                            11.76                                  13.72                        12.07  
Male (%)                                                                       31.58                          37.25                                  37.25                        39.66 
White (%)                                                                     75                               66.67                                   66.67                        63.22 
Twin (%)                                                                      76.31                           72.55                                  72.55                        66.67 
Monozygotic twin (%)                                                 52.63                           23.53                                  23.53                        36.78 
Dizygotic twin (%)                                                       23.68                          49.02                                   49.02                       29.89 
Never smoked cigarettes (%)                                       71.71                           66.67                                  33.33                        31.61 
Ever used illicit drugs (%)                                           1.97                             3.92                                     25.49                       37.36 
Alcoholic drinks /day >2  (heaviest period)                 54.61                           66.67                                  82.35                        87.93 
Age of onset (Marijuana) < 18 yr                                   -                                -                                          37.25                        50.57                         
Lifetime marijuana use > 100 times                               -                                -                                          9.80                          17.82 
Marijuana dependence (DSM criteria)                           -                                -                                          29.41                        32.76 
  
B. Descriptions and coding schemes of potential confounds 
 
The coding schemes followed by the HCP for the considered potential confounds have been described below: 
 
Total cortical surface area, average cortical thickness: total cortical surface area and average cortical thickness of each participant were 
calculated by adding the surface areas of the all cortical regions and by averaging the cortical thickness of all cortical areas reported by HCP 
respectively. 
Picture vocabulary: the measure of age adjusted perceptive vocabulary as the proxy measure of intelligence was assessed using NIH toolbox of 
picture vocabulary test(Gershon et al., 2013). 
Handedness: handedness scores vary between -100 to 100. Negative score suggests that the participant is more left-handed than right-handed and 
positive score implies that the participant is more right-handed than left-handed(Schachter et al., 1987).   
NEO-FFI measures of personality: NEO- FFI five factor model of personality(McCrae and Costa, 2004) (conscientiousness, 
extroversion/introversion, neuroticism, openness, agreeableness) was used to assess the personalities of the participants. This inventory is part of 
Penn Computerized Cognitive Battery(Gur et al., 2010).  
Delay-discounting (impulsivity/self-regulation): Humans and other animals generally discount the delayed larger reward than immediate smaller 
reward. The area under curve (AUC) based measure of delay discounting was estimated from a discounting task which finds out the 'indifference 
point' where the participant is equally likely to choose between a smaller reward ($100) shortly and the larger reward of $200 in 3 years(Estle et 
al., 2006, Myerson et al., 2001).  
 
Age, height, weight 
 
Categorically coded confounds: 
  
Binary coding:  
 
Gender (male/female), Ethnicity (white/others, black/others), Zygosity (MZ/others, DZ/others) 
 
Ordinal coding: 
 
Income (<$10,000 = 1, $10K-19,999 = 2, $20K-29,999 = 3, $30K-39,999 = 4, $40K-49,999 = 5, $50K-74,999 = 6, $75K-99,999 = 7, 
>=$100,000 = 8): total household income was reported as part of SSAGA. 
Alcoholic drinks per day (0 drink= 0 or 1 drink = 1, 2 drinks = 2, 3 drinks= 3, 4 drinks = 4, 5-6 drinks = 5, 7+ drinks= 6): Number of alcoholic 
drinks consumed per day during the twelve months of heavy drinking period in the lifetime of the participant was reported as part of SSAGA.  
Cigarettes per day (1-5 = 5; 6-10 = 10; 11-15 = 15; 16-20 = 20; >20 = 30): Number of cigarettes smoked per day during the heaviest smoking 
period of the participant was assessed as part of SSAGA. 
Illicit drug use: Total number of times illicit drugs used by the participant was assessed as part of SSAGA. 
Depressive symptoms: Number of depressive symptoms in the participant was estimated as per the DSM IV criterion of major depression. 
Childhood conduct problem: The childhood conduct problem was assessed as part of SSAGA. 
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